Related Experiment Video
Updated: Aug 9, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
Published on: June 28, 2018
Gene replacement strategies for lung cancer
1Department of Thoracic and Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
Considerable evidence has accumulated that cancer has a genetic origin based on the development of somatic mutations in families of genes responsible for critical functions of cellular DNA repair, growth control, and division. Restoration of the function of a single pivotal gene product appears sufficient to mediate antitumor effects that are potentially clinically significant. For example, restoration of wild-type p53 function in the cancer cell by gene transfer is sufficient to cause either cell-cycle arrest or apoptosis. This effect is not restricted to p53 but has been observed for oncogenes and other tumor suppressor genes as well. Genes can be delivered with sufficient efficiency by direct intratumoral injection to mediate tumor regression as shown in preclinical studies and phase I clinical trials in non-small cell lung cancer. Although clinical trials of gene replacement are in the earliest stages, this treatment offers a unique mechanism of action with a potentially high therapeutic index.
Insights
Cancer gene therapy shows promise by restoring critical gene functions to halt tumor growth. Early trials demonstrate tumor regression, offering a novel treatment with a potentially high therapeutic index.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer is understood to have a genetic origin, stemming from somatic mutations in genes controlling essential cellular functions.
- Restoring the function of key gene products can yield significant antitumor effects.
Purpose of the Study:
- To explore the potential of gene therapy in cancer treatment by restoring critical gene functions.
- To evaluate the efficacy of gene transfer for inducing tumor regression.
Main Methods:
- Gene transfer techniques, including direct intratumoral injection, were employed.
- Preclinical studies and Phase I clinical trials in non-small cell lung cancer were conducted.
Main Results:
- Restoration of wild-type p53 function via gene transfer induced cell-cycle arrest or apoptosis.
- Similar effects were observed with other oncogenes and tumor suppressor genes.
- Intratumoral gene delivery demonstrated efficiency in mediating tumor regression.
Conclusions:
- Gene replacement therapy offers a unique mechanism of action for cancer treatment.
- This approach has shown potential for clinically significant antitumor effects.
- Early-stage clinical trials suggest a potentially high therapeutic index for gene therapy in cancer.
Related Concept Videos
In-vitro Mutagenesis
Gene Therapy

